Form 4 for ANIK Anika Therapeutics, Inc.
Accepted 2022-06-10 00:00:00 ET · period of report 2022-06-08 · accession 0001171843-22-004301 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-10 | 2022-06-08 | ANIK | Richard Stephen | Dir | A - Grant | $0.00 | +7,954 | 21.4K | +59% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-08 | A | A | 7,954 | $0.00 | 21,436 | D | — | — | (F1) These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on the earlier of the 2023 annual meeting of the Company's stockholders or June 8, 2023. |